FOXO חוב כולל להון FOXO Technologies Inc.

FOXO Technologies (FOXO) develops AI tools for determining biological age, although its market influence remains limited due to the current implementation stage. The company helps insurers minimize risks through biomarker analysis, which supports stability within the logistics sector. The firm's autonomous algorithms provide high-precision epigenetic longevity calculations. The total debt-to-equity ratio stands at 0.00, as clearly demonstrated by the share price retrospective below.

For FOXO Technologies (FOXO), which has shifted its strategic focus toward AI implementation, this indicator determines the balance between borrowed funds and equity. By analyzing the liability structure—specifically total debt to equity—an investor assesses the financial leverage: while excessive leverage can amplify returns, it exponentially increases the risk of insolvency during revenue declines amidst the management's strategic adaptation.